上海金畔生物科技有限公司代理AAT Bioquest荧光染料全线产品,欢迎访问AAT Bioquest荧光染料官网了解更多信息。
柯胺G CAS 6472-91-9
货号 | 23055 | 存储条件 | 在零下15度以下保存, 避免光照 | |
规格 | 5 mg | 价格 | 1008 | |
Ex (nm) | 386 | Em (nm) | ||
分子量 | 482.44 | 溶剂 | DMSO | |
产品详细介绍 |
简要概述
产品基本信息
货号:23055
产品名称:柯胺G
CAS:6472-91-9
规格:5mg
储存条件:-15℃避光防潮
保质期:24个月
产品物理化学光谱特性
分子量:482.44
溶剂:DMSO
激发波长(nm):386
发射波长(nm):N/A
产品介绍
Chrysamine G是刚果红的亲脂性双水杨酸类似物,具有高(Kd = 200 nM; Bmax = 1.13摩尔/摩尔Ab40)和低(Kd = 38.77 µM; Bmax = 23.10摩尔/摩尔Ab40)。 β-淀粉样蛋白(Ab)原纤维的亲和力结合位点。 它可以穿过血脑屏障,并可用作检测老年斑(Ab聚集体)的有用探针。金畔生物是AAT Bioquest的中国代理商,为您提供最优质的柯胺G。
参考文献
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo
Authors: Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM.
Journal: J Biol Chem (2005): 5892
Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain
Authors: Mathis CA, Wang Y, Klunk WE.
Journal: Curr Pharm Des (2004): 1469
Amyloid binding ligands as Alzheimer’s disease therapies
Authors: Lee VM.
Journal: Neurobiol Aging (2002): 1039
Chrysamine G and its derivative reduce amyloid beta-induced neurotoxicity in mice
Authors: Ishii K, Klunk WE, Arawaka S, Debnath ML, Furiya Y, Sahara N, Shoji S, Tamaoka A, Pettegrew JW, Mori H.
Journal: Neurosci Lett (2002): 5
Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative
Authors: Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT.
Journal: J Neuropathol Exp Neurol (2002): 797
Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis
Authors: Dezutter NA, L and man WJ, Jager PL, de Groot TJ, Dupont PJ, Tooten PC, Zekarias B, Gruys E, Verbruggen AM.
Journal: Amyloid (2001): 202
In search of the ideal radiotracer for soft-tissue amyloid scanning
Authors: Lee VW, Shah NP.
Journal: Amyloid (2001): 220
In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis
Authors: Dezutter NA, Sciot RM, de Groot TJ, Bormans GM, Verbruggen AM.
Journal: Nucl Med Commun (2001): 553
Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles
Authors: Smith DL, Portier R, Woodman B, Hockly E, Mahal A, Klunk WE, Li XJ, Wanker E, Murray KD, Bates GP.
Journal: Neurobiol Dis (2001): 1017
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington’s disease therapy
Authors: Heiser V, Scherzinger E, Boeddrich A, Nordhoff E, Lurz R, Schugardt N, Lehrach H, Wanker EE.
Journal: Proc Natl Acad Sci U S A (2000): 6739